Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Active treatment can help prevent scarring hair loss in SLE patients.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

SLE and DM can coexist but are rare and need careful evaluation.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

A thorough, team-based approach and clear communication improve outcomes in complex neuropsychiatric lupus cases.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

The 2012 criteria are better for diagnosing atypical lupus cases.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.